戻る Agendas
Session 2: 5th Anniversary of the Guidance for Bayesian Statistics
Session Chair(s)
Laura Thompson, PHD
Mathematical Statistician, CDRH
FDA , United States
Speaker(s)
An FDA Perspective on the 5th Anniversary of the Guidance on the Use of Bayesian Statistics in Medical Device Clinical Trials
Gregory Campbell, PHD
FDA, United States
Director, Division of Biostatistics, CDRH
Industry’s Perspective
Roger Lewis, MD, PHD
Berry Consultants, LLC, United States
Senior Medical Scientist
Q&A Panel Discussion - Joining the speakers:
Karen Lynn Price, PHD
Eli Lilly and Company, United States
Senior Research Fellow, Statistical Innovation Center/Design Hub
Donald A Berry, PHD
M.D. Anderson Cancer Center, United States
Professor, Department of Biostatistics
Estelle Russek-Cohen, PHD
FDA, United States
Senior Advisor, Office of Biostat